Opaganib, de RedHill Biopharma, inhibe las variantes de la COVID-19 en un ensayo preclínico ...Middle East

Opaganib inhibe fuertemente las variantes de la COVID-19 Beta (Sudáfrica) y Gamma (Brasil), lo que respalda aún más su actividad antiviral También está previsto que el enfoque antivírico y antiinflamatorio dual, único, administrado por vía oral, dirigido al huésped y único de Opaganib...

Hence then, the article about opaganib de redhill biopharma inhibe las variantes de la covid 19 en un ensayo preclinico was published today ( Tuesday 29/06/2021 - 09:15 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Opaganib, de RedHill Biopharma, inhibe las variantes de la COVID-19 en un ensayo preclínico )

Also on site :

• Hollywood mourns loss of beloved makeup artist Jasen Kaplan
• Suspected mountain lion attack in Colorado mountains under investigation
• Person falls to death on Boylston Street on New Year’s Eve